CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

October 19, 2026 · Acquisition

SLN Acquisition: a positive outcome, +125.6%

On October 19, 2026, Silence Therapeutics plc reached its Acquisition. The result was a positive outcome, and the stock moved +125.6% in the window around the event. It had already run -28.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$8.68
1d before
$19.58
Event day
$19.61
1d after
$19.64
5d after

Pre-catalyst setup

-28.9%
30-day run-up
5165%
30-day volatility
1.0×
volume spike